| Product Code: ETC13235762 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Adult Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Adult Vaccine Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Adult Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Adult Vaccine Market - Industry Life Cycle |
3.4 Africa Adult Vaccine Market - Porter's Five Forces |
3.5 Africa Adult Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Adult Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Adult Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Africa Adult Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Africa Adult Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
4 Africa Adult Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Adult Vaccine Market Trends |
6 Africa Adult Vaccine Market, 2021 - 2031 |
6.1 Africa Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Adult Vaccine Market, Revenues & Volume, By Subunit, 2021 - 2031 |
6.1.3 Africa Adult Vaccine Market, Revenues & Volume, By mRNA, 2021 - 2031 |
6.1.4 Africa Adult Vaccine Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.5 Africa Adult Vaccine Market, Revenues & Volume, By Live attenuated, 2021 - 2031 |
6.1.6 Africa Adult Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.2 Africa Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Adult Vaccine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Africa Adult Vaccine Market, Revenues & Volume, By Nasal, 2021 - 2031 |
6.2.4 Africa Adult Vaccine Market, Revenues & Volume, By Prenteral, 2021 - 2031 |
6.3 Africa Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Adult Vaccine Market, Revenues & Volume, By Viral Diseases, 2021 - 2031 |
6.3.3 Africa Adult Vaccine Market, Revenues & Volume, By Bacterial Vaccines, 2021 - 2031 |
6.3.4 Africa Adult Vaccine Market, Revenues & Volume, By Cancer Vaccines, 2021 - 2031 |
6.3.5 Africa Adult Vaccine Market, Revenues & Volume, By Allergy Vaccines, 2021 - 2031 |
6.4 Africa Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Adult Vaccine Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.4.3 Africa Adult Vaccine Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
7 Africa Adult Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Adult Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
7.3.1 South Africa Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3.2 Egypt Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3.3 Nigeria Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3.4 Rest of Africa Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4 Africa Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.1 South Africa Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.2 Egypt Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.3 Nigeria Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.4 Rest of Africa Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 Africa Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5.1 South Africa Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5.2 Egypt Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5.3 Nigeria Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5.4 Rest of Africa Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8 Africa Adult Vaccine Market Key Performance Indicators |
9 Africa Adult Vaccine Market - Export/Import By Countries Assessment |
10 Africa Adult Vaccine Market - Opportunity Assessment |
10.1 Africa Adult Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Adult Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Adult Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.4 Africa Adult Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.5 Africa Adult Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
11 Africa Adult Vaccine Market - Competitive Landscape |
11.1 Africa Adult Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Africa Adult Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |